WallStreetZenWallStreetZen

NASDAQ: MESO
Mesoblast Ltd Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Be the first to know when Wall Street analysts revise their MESO stock forecasts and price targets.

Forecast return on equity

Is MESO forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
35.42%

Forecast return on assets

Is MESO forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

MESO revenue forecast

What is MESO's revenue in the next 3 years based on estimates from 2 analysts?
Avg 1 year Forecast
$7.4M+2.65%
Avg 2 year Forecast
$7.8M+6.85%
Avg 3 year Forecast
$34.0M+368.77%
MESO's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

MESO revenue growth forecast

How is MESO forecast to perform vs Biotechnology companies and vs the US market?
Company
54.19%
Industry
37.5%
Market
10.08%
MESO's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
MESO's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

MESO vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
MESO$6.22N/AN/A
DNTH$21.32$41.75+95.83%Strong Buy
HLVX$12.58$30.67+143.78%Strong Buy
CABA$12.96$34.33+164.92%Strong Buy
PROK$2.71$2.50-7.75%Hold
View Top Biotech Stocks

Mesoblast Stock Forecast FAQ

What is MESO's revenue growth forecast for 2024-2026?

(NASDAQ: MESO) Mesoblast's forecast annual revenue growth rate of 54.19% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.5%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.08%.

Mesoblast's revenue in 2024 is $7,253,000.On average, 2 Wall Street analysts forecast MESO's revenue for 2024 to be $7,555,181,042, with the lowest MESO revenue forecast at $6,991,967,411, and the highest MESO revenue forecast at $8,118,394,672. On average, 2 Wall Street analysts forecast MESO's revenue for 2025 to be $7,864,694,839, with the lowest MESO revenue forecast at $7,610,995,005, and the highest MESO revenue forecast at $8,118,394,672.

In 2026, MESO is forecast to generate $34,503,177,356 in revenue, with the lowest revenue forecast at $34,503,177,356 and the highest revenue forecast at $34,503,177,356.

If you're new to stock investing, here's how to buy Mesoblast stock.

What is MESO's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: MESO) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is MESO's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: MESO) forecast ROE is N/A, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.